Oceana To Launch Solesta For Fecal Incontinence By September
This article was originally published in The Gray Sheet
Executive SummaryOceana Therapeutics plans to double its sales force over the summer by hiring 10 additional reps in preparation for a September launch of its newly approved Solesta bulking agent for fecal incontinence.
You may also be interested in...
Although privately held Oceana’s two products – Solesta and Deflux – are regulated by FDA as Class III medical devices, Salix intends to market them with existing sales forces.